Related Experiment Video
Updated: Dec 30, 2025

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
Published on: September 30, 2021
Fundamentals for a Systematic Approach to Mild and Moderate Inherited Bleeding Disorders: An EHA Consensus Report
Francesco Rodeghiero1, Ingrid Pabinger2, Margaret Ragni3
1Hematology Project Foundation, Vicenza, Italy, affiliated to the Hematology Department, San Bortolo Hospital, Vicenza, Italy.
Distinguishing normal bleeding from pathologic bleeding is crucial. A new framework for mild-to-moderate bleeding disorders (MBD) offers a systematic diagnostic approach for better patient counseling and treatment.
Area of Science:
- Hematology
- Clinical Diagnostics
- Patient Management
Background:
- Minor bleeding is common, but distinguishing it from pathologic bleeding is critical for patient care.
- Mild-to-moderate bleeding disorders (MBD) are common but lack standardized diagnostic and management guidelines.
- Fragmented knowledge hinders effective counseling and treatment for patients with excessive bleeding.
Approach:
- An International Working Group (IWG) by the European Hematology Association (EHA) developed consensus-based guidelines.
- Grouping disorders by clinical phenotype into mild-to-moderate bleeding disorders (MBD) facilitates a systematic diagnostic approach.
- A conceptual unified framework and patient-centered diagnostic approach are proposed to classify MBD.
Key Points:
- Standardized definitions and a unified framework aim to differentiate normal bleeding from MBD.
- The proposed diagnostic approach classifies MBD into distinct clinical-pathological entities.
- Focus on clinical utility for the individual patient guides the diagnostic strategy.
Conclusions:
- The developed framework provides a systematic approach to diagnosing MBD.
- This conceptual framework will inform evidence-based, disease-specific guidelines.
- Improved diagnostic clarity is essential for effective management and counseling of MBD patients.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Venous Thrombosis IV: Nursing Management

